1-3 of 3
Jeremy Segal
Close
Sort by
Journal Articles

Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults

Hannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, Anand A. Patel, Adam DuVall, Peng Wang, Pankhuri Wanjari, Jeremy Segal, Girish Venkataraman, Jason X. Cheng, Sandeep Gurbuxani, Angela Lager, Carrie Fitzpatrick, Michael Thirman, Mariam Nawas, Hongtao Liu, Michael Drazer, Olatoyosi Odenike, Richard Larson, Wendy Stock, Caner Saygin
Journal: Blood Advances
Blood Adv (2023) 8 (1): 164–171.
https://doi.org/10.1182/bloodadvances.2023011862
Published: 2023
Includes: Supplemental data
Journal Articles

Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement

Clinical Trials & Observations
Timothy Carll, Anand Patel, Benjamin Derman, Elizabeth Hyjek, Angela Lager, Pankhuri Wanjari, Jeremy Segal, Olatoyosi Odenike, Shiraz Fidai, Daniel Arber
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4924–4928.
https://doi.org/10.1182/bloodadvances.2019001282
Published: 2020
Includes: Supplemental data
Journal Articles

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia

Clinical Trials & Observations
Kirk E. Cahill, Yasmin H. Karimi, Theodore G. Karrison, Nitin Jain, Margaret Green, Howard Weiner, Noreen Fulton, Sabah Kadri, Lucy A. Godley, Andrew S. Artz, Hongtao Liu, Michael J. Thirman, Michelle M. Le Beau, Megan E. McNerney, Jeremy Segal, Richard A. Larson, Wendy Stock, Olatoyosi Odenike
Journal: Blood Advances
Blood Adv (2020) 4 (4): 599–606.
https://doi.org/10.1182/bloodadvances.2019000795
Published: 2020
Includes: Supplemental data